Come see us at booth number 528 for this year�s 112th ASCPT Annual Meeting, the premier event for clinical pharmacologists, taking place 2nd to 5th March 2011 in Dallas, Texas.What�s on offer?

  • Over 30 educational sessions and 300 poster presentations
  • Lectures from top professionals in the industry
  • Networking opportunities with clinical pharmacologists from  around the world

Dr J rg fT ubel, medical practitioner and CEO of Richmond Pharmacology, will be presenting two of Richmond Pharmacology s latest publications centred on the following key areas of discussion:

  • COMPARISON OF DIGITAL 12-LEAD ECG AND DIGITAL 12-LEAD HOLTER ECG RECORDINGS IN HEALTHY MALE SUBJECTS - Poster Number: PI-08, scheduled on 3/3/2011 from 8:00 AM
  • FOOD EFFECT ON QTC INTERVAL IN THOROUGH QT STUDIES CONDUCTED IN HEALTHY SUBJECTS - Poster Number: LBII-1, scheduled on 4/3/2011 from 8.00 AM to 9.30 AM

For further details, please refer to the online brochure for program highlights, a schedule of events, student and trainee events.We look forward to seeing you in Dallas!

Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event